SMAD3 prevents graft-versus-host disease by restraining Th1 differentiation and granulocyte-mediated tissue damage

Blood

Volumn 117, Issue 5, 2011, Pages 1734-1744

  Giroux, Martin ^a,b   Delisle, Jean Sébastien ^a,b,c   Gauthier, Simon David ^a   Heinonen, Krista M ^a   Hinsinger, Julie ^a   Houde, Billy ^a   Gaboury, Louis ^a   Brochu, Sylvie ^a   Wu, Jiangping ^b,d   Hébert, Marie Josée ^b,d   Perreault, Claude ^a,b,c  

^a INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

^c MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

^d CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

SMAD3 PROTEIN; TRANSCRIPTION FACTOR T BET;

ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CONTROLLED STUDY; DISEASE SEVERITY; GRAFT VERSUS HOST REACTION; GRANULOCYTE; HISTOCOMPATIBILITY COMPLEX; HUMAN; LYMPHOID CELL; MOUSE; NITROSATIVE STRESS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; TH1 CELL; TISSUE INJURY;

EID: 79551621098     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2010-05-287649     Document Type: Article

References (50)

1. Ferrara JL, Levine JE, Reddy P, Holler E. Graft-versus-host disease. Lancet. 2009;373(9674):1550-1561.
2. Socie G, Blazar BR. Acute graft-versus-host disease: from the bench to the bedside. Blood. 2009;114(20):4327-4336.
3. Jenq RR, van den Brink MR. Allogeneic haematopoietic stem cell transplantation: individualized stem cell and immune therapy of cancer. Nat Rev Cancer. 2010;10(3):213-221.
4. Negrin RS, Contag CH. In vivo imaging using bioluminescence: a tool for probing graft-versus-host disease. Nat Rev Immunol. 2006;6(6):484-490.
5. Shlomchik WD. Graft-versus-host disease. Nat Rev Immunol. 2007;7(5):340-352.
6. Sykes M, Woods K, Sachs DH. Transplantation immunology. In: Paul WE, ed. Fundamental Immunology. 6th ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2008:1426-1488.
7. Baron C, Somogyi R, Greller LD, et al. Prediction of graft-versus-host disease in humans by donor gene expression profiling. PLoS Med. 2007;4(1):e23.
8. Busque L, Belisle C, Provost S, Giroux M, Perreault C. Differential expression of SMAD3 transcripts is not regulated by cis-acting genetic elements but has a gender specificity. Genes Immun. 2009;10(2):192-196.
9. Wildey GM, Patil S, Howe PH. Smad3 potentiates transforming growth factor beta (TGFbeta)-induced apoptosis and expression of the BH3-only protein Bim in WEHI 231 B lymphocytes. J Biol Chem. 2003;278(20):18069-18077. (Pubitemid 36799419)
10. Poncelet AC, Schnaper HW, Tan R, Liu Y, Runyan CE. Cell phenotype-specific down-regulation of Smad3 involves decreased gene activation as well as protein degradation. J Biol Chem. 2007;282(21):15534-15540. (Pubitemid 47093313)
11. Daly AC, Vizan P, Hill CS. Smad3 protein levels are modulated by Ras activity and during the cell cycle to dictate transforming growth factor-beta responses. J Biol Chem. 2010;285(9):6489-6497.
12. Giroux M, Delisle JS, O'Brien A, Hebert MJ, Perreault C. T cell activation leads to protein kinase Cθ-dependent inhibition of TGF-beta signaling. J Immunol. 2010;185(3):1568-1576.
13. Taylor IW, Wrana JL. SnapShot: the TGFbeta pathway interactome. Cell. 2008;133(2):378.
14. Derynck R, Zhang YE. Smad-dependent and Smad-independent pathways in TGF-beta family signalling. Nature. 2003;425(6958):577-584.
15. Li MO,Wan YY, Sanjabi S, Robertson AK, Flavell RA. Transforming growth factor-beta regulation of immune responses. Annu Rev Immunol. 2006;24:99-146.
16. Marie JC, Liggitt D, Rudensky AY. Cellular mechanisms of fatal early-onset autoimmunity in mice with the T cell-specific targeting of transforming growth factor-beta receptor. Immunity. 2006;25(3):441-454.
17. Li MO, Flavell RA. TGF-beta: a master of all T cell trades. Cell. 2008;134(3):392-404.
18. Li L, Iwamoto Y, Berezovskaya A, Boussiotis VA. A pathway regulated by cell cycle inhibitor p27Kip1 and checkpoint inhibitor Smad3 is involved in the induction of T cell tolerance. Nat Immunol. 2006;7(11):1157-1165. (Pubitemid 44594311)
19. Maggio-Price L, Treuting P, Zeng W, Tsang M, Bielefeldt-Ohmann H, Iritani BM. Helicobacter infection is required for inflammation and colon cancer in SMAD3-deficient mice. Cancer Res. 2006;66(2):828-838.
20. Giroux M, Yurchenko E, St-Pierre J, Piccirillo CA, Perreault C. T regulatory cells control numbers of NK cells and immature denditic CD8alpha+ cells in the lymph node paracortex. J Immunol. 2007;179(7):4492-4502.
21. Delisle JS, Gaboury L, Bélanger MP, Tassé E, Yagita H, Perreault C. GVHD causes failure of donor hematopoiesis and lymphopoiesis in IFNgamma receptor-deficient hosts. Blood. 2008;112(5):2111-2119.
22. Daley JM, ThomayAA, Connolly MD, Reichner JS, Albina JE. Use of Ly6G-specific monoclonal antibody to deplete neutrophils in mice. J Leukoc Biol. 2008;83(1):64-70.
23. Asavaroengchai W, Wang H, Wang S, et al. An essential role for IFN-gamma in regulation of alloreactive CD8 T cells following allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2007;13(1):46-55.
24. Brochu S, Baron C, Hetu F, Roy DC, Perreault C. Oligoclonal expansion of CTLs directed against a restricted number of dominant minor histocompatibility antigens in hemopoietic chimeras. J Immunol. 1995;155(11):5104-5114.
25. Gudmundsdottir H, Wells AD, Turka LA. Dynamics and requirements of T cell clonal expansion in vivo at the single-cell level: effector function is linked to proliferative capacity. J Immunol. 1999;162(9):5212-5223. (Pubitemid 29307126)
26. McKarns SC, Schwartz RH. Distinct effects of TGF-beta 1 on CD4+ and CD8+ T cell survival, division, and IL-2 production: a role for T cell intrinsic Smad3. J Immunol. 2005;174(4):2071-2083.
27. Fowler DH, Gress RE. Graft-vs.-host disease as a Th1-type process: regulation by Th2-type cells. In: Ferrara JLM, Cooke KR, Deeg HJ, eds. Graftvs.- Host Disease. 3rd ed. New York, NY: Marcel Dekker; 2005:59-82.
28. Trenado A, Charlotte F, Fisson S, et al. Recipient-type specific CD4+CD25+ regulatory T cells favor immune reconstitution and control graft-versus-host disease while maintaining graft-versusleukemia. J Clin Invest. 2003;112(11):1688-1696.
29. Richardson MP, Ayliffe MJ, Helbert M, Davies EG. A simple flow cytometry assay using dihydrorhodamine for the measurement of the neutrophil respiratory burst in whole blood: comparison with the quantitative nitrobluetetrazolium test. J Immunol Methods. 1998;219(1-2):187-193.
30. Socie G, Mary JY, Lemann M, et al. Prognostic value of apoptotic cells and infiltrating neutrophils in graft-versus-host disease of the gastrointestinal tract in humans: TNF and Fas expression. Blood. 2004;103(1):50-57.
31. Harrington LE, Galvan M, Baum LG, Altman JD, Ahmed R. Differentiating between memory and effector CD8 T cells by altered expression of cell surface O-glycans. J Exp Med. 2000;191(7):1241-1246.
32. Baron C, Meunier MC, Caron E, et al. Asynchronous differentiation of CD8 T cells that recognize dominant and cryptic antigens. J Immunol. 2006;177(12):8466-8475.
33. Schroder K, Hertzog PJ, Ravasi T, Hume DA. Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol. 2004;75(2):163-189.
34. Soehnlein O, Oehmcke S, Ma X, et al. Neutrophil degranulation mediates severe lung damage triggered by streptococcal M1 protein. Eur Respir J. 2008;32(2):405-412.
35. Forlenza M, Scharsack JP, Kachamakova NM, Taverne-Thiele AJ, Rombout JH, Wiegertjes GF. Differential contribution of neutrophilic granulocytes and macrophages to nitrosative stress in a host-parasite animal model. Mol Immunol. 2008;45(11):3178-3189.
36. Classen S, Zander T, Eggle D, et al. Human resting CD4+ T cells are constitutively inhibited by TGFbeta under steady-state conditions. J Immunol. 2007;178(11):6931-6940.
37. Brown KA, Pietenpol JA, Moses HL. A tale of two proteins: differential roles and regulation of Smad2 and Smad3 in TGF-beta signaling. J Cell Biochem. 2007;101(1):9-33.
38. Muller I, Munder M, Kropf P, Hansch GM. Polymorphonuclear neutrophils and T lymphocytes: strange bedfellows or brothers in arms? Trends Immunol. 2009;30(11):522-530.
39. Yi T, Chen Y, Wang L, et al. Reciprocal differentiation and tissue-specific pathogenesis of Th1, Th2, and Th17 cells in graft-versus-host disease. Blood. 2009;114(14):3101-3112.
40. Nava P, Koch S, Laukoetter MG, et al. Interferon-γ regulates intestinal epithelial homeostasis through converging beta-catenin signaling pathways. Immunity. 2010;32(3):392-402.
41. Burman AC, Banovic TD, Kuns RD, et al. IFN-gamma differentially controls the development of idiopathic pneumonia syndrome and GVHD of the gastrointestinal tract. Blood. 2007;110(3):1064-1072.
42. Neurath MF, Weigmann B, Finotto S, et al. The transcription factor T-bet regulates mucosal T cell activation in experimental colitis and Crohn's disease. J Exp Med. 2002;195(9):1129-1143.
43. Teshima T, Ordemann R, Reddy P, et al. Acute graft-versus-host disease does not require alloantigen expression on host epithelium. Nat Med. 2002;8(6):575-581.
44. Matte-Martone C, Liu J, Jain D, McNiff J, Shlomchik WD. CD8+ but not CD4+ T cells require cognate interactions with target tissues to mediate GVHD across only minor H antigens whereas both CD4+ and CD8+ T cells require direct leukemic contact to mediate GVL. Blood. 2008;111(7):3884-3892.
45. Zecher D, van Rooijen N, Rothstein DM, Shlomchik WD, Lakkis FG. An innate response to allogeneic nonself mediated by monocytes. J Immunol. 2009;183(12):7810-7816.
46. Soehnlein O. An elegant defense: how neutrophils shape the immune response. Trends Immunol. 2009;30(11):511-512.
47. Banovic T, MacDonald KP, Morris ES, et al. TGF-beta in allogeneic stem cell transplantation: friend or foe? Blood. 2005;106(6):2206-2214. (Pubitemid 41291742)
48. McCormick LL, Zhang Y, Tootell E, Gilliam AC. Anti-TGF-beta treatment prevents skin and lung fibrosis in murine sclerodermatous graft-versus-host disease: a model for human scleroderma. J Immunol. 1999;163(10):5693-5699.
49. Mennechet FJ, Kasper LH, Rachinel N, et al. Intestinal intraepithelial lymphocytes prevent pathogen- driven inflammation and regulate the Smad/ T-bet pathway of lamina propria CD4+ T cells. Eur J Immunol. 2004;34(4):1059-1067. (Pubitemid 39255984)
50. Fujii T, Ohtsuka Y, Lee T, et al. Bifidobacterium breve enhances transforming growth factor beta1 signaling by regulating Smad7 expression in preterm infants. J Pediatr Gastroenterol Nutr. 2006; 43(1):83-88.